Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study

Daniel Albjerg Rudolph, Stine Munk Hald, Luis Alberto García Rodríguez, Sören Möller, Jesper Hallas, Larry B Goldstein, David Gaist

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


BACKGROUND AND OBJECTIVES: A causal relationship between long-term statin use and the risk of intracerebral hemorrhage (ICH) remains uncertain. We investigated the association between statin use prior to hospital admission for ICH in a Danish population-based, nationwide case-control study.

METHODS: We used the Danish Stroke Registry to identify all patients age ≥45-years with a first-ever ICH between 2005-2018. ICH cases were matched for age, sex, and calendar year to controls selected from the general population. A medication registry with information on all dispensed prescriptions at community pharmacies in Denmark since 1995 was used to ascertain prior statin exposure that was classified for recency, duration, and intensity. Using conditional regression and adjusting for potential confounders, we calculated adjusted odds ratios (aORs) and corresponding 95% confidence intervals (CIs) for the risk of ICH.

RESULTS: The study population consisted of 16,235 patients with ICH and 640,943 controls. Current statin use (cases 25.9% vs controls 24.5%; aOR 0.74, 95% CI, 0.71-0.78) and longer duration of current statin use (<1 year: aOR 0.86; 95%CI, 0.81-0.92; ≥1 to <5 years: aOR 0.72; 95%CI, 0.68-0.76; ≥5 to <10 years: aOR 0.65; 95%CI, 0.60-0.71; ≥10 years of use, 0.53; 95%CI 0.45-0.62; P for trend <0.001) were associated with lower risk of ICH. Similar treatment duration relationships were found in analyses stratified by statin use intensity (high intensity therapy: <1 year of use, aOR 0.78; 95%CI, 0.66-0.93; ≥10 years of use: 0.46; 95% CI 0.33-0.65; P for trend 0.001).

DISCUSSION: We found that longer duration of statin use is associated with a lower risk of ICH.

CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that current statin use and longer duration of statin use are each associated with a lower risk of ICH.

Udgave nummer7
Sider (fra-til)E711-E719
StatusUdgivet - 16. aug. 2022

Bibliografisk note

© 2022 American Academy of Neurology.


Dyk ned i forskningsemnerne om 'Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study'. Sammen danner de et unikt fingeraftryk.